Sanara Ventures adds two medtech startups to tech incubator
Sanara Ventures adds two medtech startups to tech incubator
The two Israeli startups, Panacea and ActiveAging, will join Sanara’s portfolio of over 20 companies.
Sanara Ventures has added two new startup companies from the field of digital medicine, Panacea and ActiveAging, to its technology incubator. Both were approved by the Israel Innovation Authority and an agreement was signed between them and the group.
Panacea has developed a software system that enables pharmaceutical companies and companies that perform clinical studies to prepare, perform and analyze clinical trials in an optimal manner, thus shortening processes and time while saving money. With the help of machine learning, AI and advanced data analysis capabilities, Panacea is developing the next generation of clinical trials that will be shorter, more efficient, cheaper and more informative and with higher chances of success. The company currently has six pilots with potential for commercial success.
ActiveAging has developed an AI-based cloud platform that enables medical insurance companies to manage cost-effective, efficient and continuous personalized health benefits for elderly and chronically ill customers, in order to improve member retention and reduce medical expenses. The company allows the insurance companies to follow each customer throughout the personal health journey, to calculate and monitor the dynamic risk specific to the patient in real time, thus offering the exact complementary benefit and service to the customer.
Sanara Ventures is the investment platform which focuses on startups in the pre-seed, Seed and round A stages and has over 20 portfolio companies. Recently, Sanara launched Sanara Capital, which is raising $100 million with the medical device giant Philips to invest in startups in more advanced stages.
